Merlin Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 19-06-2024
- Paid Up Capital ₹ 1.31 Cr
as on 19-06-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.73 Cr
as on 19-06-2024
- Satisfied Charges ₹ 0.65 Cr
as on 19-06-2024
- Revenue 33.84%
(FY 2022)
- Profit 44.61%
(FY 2022)
- Ebitda 83.19%
(FY 2022)
- Net Worth 17.63%
(FY 2022)
- Total Assets 29.00%
(FY 2022)
About Merlin Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.31 Cr.
The company currently has active open charges totaling ₹10.73 Cr. The company has closed loans amounting to ₹6.53 M, as per Ministry of Corporate Affairs (MCA) records.
Anoop Mangal and Sureshchand Mangal serve as directors at the Company.
- CIN/LLPIN
U24230MH1988PTC048460
- Company No.
048460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Merlin Pharma Private Limited offer?
Merlin Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Pain Relief Drugs & Pharmaceuticals, Anesthetic.
Who are the key members and board of directors at Merlin Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anoop Mangal  | Director | 01-Jul-1994 | Current |
| Sureshchand Mangal | Director | 11-Aug-1988 | Current |
Financial Performance and Corporate Structure Insights of Merlin Pharma.
Merlin Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.84% increase. The company also saw a substantial improvement in profitability, with a 44.61% increase in profit. The company's net worth Soared by an impressive increase of 17.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merlin Pharma?
Unlock access to Merlin Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Mar 2024 | ₹9.75 M | Open |
Others Creation Date: 11 Mar 2024 | ₹9.75 Cr | Open |
Central Bank Of India Creation Date: 30 Aug 1989 | ₹0.68 M | Satisfied |
How Many Employees Work at Merlin Pharma?
Merlin Pharma has a workforce of 7 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merlin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merlin Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
